150 related articles for article (PubMed ID: 3951319)
1. Loss of morphine hyperphagia following neonatal monosodium glutamate treatment in rats.
Bodnar RJ; Mann PE; Romero MT; Truesdell LS
Life Sci; 1986 Mar; 38(10):947-50. PubMed ID: 3951319
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions.
Meister B; Ceccatelli S; Hökfelt T; Andén NE; Andén M; Theodorsson E
Exp Brain Res; 1989; 76(2):343-68. PubMed ID: 2569986
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of opioid and nonopioid analgesic responses following adult monosodium glutamate pretreatment.
Sathaye N; Bodnar RJ
Physiol Behav; 1989 Aug; 46(2):217-22. PubMed ID: 2602462
[TBL] [Abstract][Full Text] [Related]
4. Neonatal treatment with monosodium-L-glutamate: differential effects on growth hormone and prolactin release induced by morphine.
Antoni FA; Kanyicska B; Mezey E; Makara GB
Neuroendocrinology; 1982 Oct; 35(4):231-5. PubMed ID: 7145019
[TBL] [Abstract][Full Text] [Related]
5. Neonatal monosodium glutamate. Effects upon analgesic responsivity and immunocytochemical ACTH/beta-lipotropin.
Bodnar RJ; Abrams GM; Zimmerman EA; Krieger DT; Nicholson G; Kizer JS
Neuroendocrinology; 1980 May; 30(5):280-4. PubMed ID: 6247667
[TBL] [Abstract][Full Text] [Related]
6. Differential alterations in opioid analgesia following neonatal monosodium glutamate treatment.
Bodnar RJ; Portzline T; Nilaver G
Brain Res Bull; 1985 Sep; 15(3):299-305. PubMed ID: 2932202
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Tang-Christensen M; Vrang N; Larsen PJ
Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
Bodnar RJ; Truesdell LS; Nilaver G
Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
[TBL] [Abstract][Full Text] [Related]
9. Effects of neonatal exposure to monosodium glutamate on the electrical activity of neurones in the mediobasal hypothalamus, and on the plasma concentrations of thyroid-stimulating hormone and prolactin, following stimulation of the rostral hypothalamus in adult female rats.
Saphier DJ; Dyer RG
J Endocrinol; 1981 Jun; 89(3):379-87. PubMed ID: 7252399
[TBL] [Abstract][Full Text] [Related]
10. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence.
Bloch B; Ling N; Benoit R; Wehrenberg WB; Guillemin R
Nature; 1984 Jan 19-25; 307(5948):272-3. PubMed ID: 6420704
[TBL] [Abstract][Full Text] [Related]
11. Impairments in analgesic, hypothermic, and glucoprivic stress responses following neonatal monosodium glutamate.
Badillo-Martinez D; Nicotera N; Butler PD; Kirchgessner AL; Bodnar RJ
Neuroendocrinology; 1984 Jun; 38(6):438-46. PubMed ID: 6738808
[TBL] [Abstract][Full Text] [Related]
12. Monosodium glutamate-induced reductions in hypothalamic beta-endorphin content result in mu-opioid receptor upregulation in the medial preoptic area.
Desjardins GC; Brawer JR; Beaudet A
Neuroendocrinology; 1992 Sep; 56(3):378-84. PubMed ID: 1331839
[TBL] [Abstract][Full Text] [Related]
13. [Effects of neonatal administration of monosodium glutamate on morphine-, acupuncture- and stress-analgesia in adult rats].
Guo SY; Yin WP; Yin QZ
Zhongguo Yao Li Xue Bao; 1983 Mar; 4(1):14-6. PubMed ID: 6223490
[No Abstract] [Full Text] [Related]
14. Corticoliberin and somatoliberin activity in the pituitary stalk median eminence of rats after neonatal treatment with monosodium glutamate.
Acs Z; Antoni FA; Makara GB
J Endocrinol; 1982 May; 93(2):239-45. PubMed ID: 6806420
[TBL] [Abstract][Full Text] [Related]
15. Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment.
Leitner C; Bartness TJ
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R775-83. PubMed ID: 18094070
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y in the specific hypothalamic nuclei of rats treated neonatally with monosodium glutamate.
Abe M; Saito M; Shimazu T
Brain Res Bull; 1990 Feb; 24(2):289-91. PubMed ID: 2322864
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects of monosodium glutamate on the dopaminergic and GABAergic innervations of the median eminence and the intermediate lobe in the mouse.
Stoeckel ME; Tappaz M; Hindelang C; Seweryn C; Porte A
Neurosci Lett; 1985 May; 56(3):249-55. PubMed ID: 2862609
[TBL] [Abstract][Full Text] [Related]
18. Developmental and sex-specific effects of low dose neonatal monosodium glutamate administration on mediobasal hypothalamic chemistry.
Dawson R
Neuroendocrinology; 1986; 42(2):158-66. PubMed ID: 3513043
[TBL] [Abstract][Full Text] [Related]
19. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor.
Millard WJ; Martin JB; Audet J; Sagar SM; Martin JB
Endocrinology; 1982 Feb; 110(2):540-50. PubMed ID: 6120072
[TBL] [Abstract][Full Text] [Related]
20. Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia.
Scallet AC; Olney JW
Brain Res; 1986 May; 374(2):380-4. PubMed ID: 3459567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
